Note 20 - Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Notes Tables |
|
| Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] |
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| Current: |
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. federal |
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
7 |
|
| U.S. state and local |
|
|
1 |
|
|
|
— |
|
|
|
1 |
|
| Foreign |
|
|
57 |
|
|
|
75 |
|
|
|
66 |
|
| Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. federal |
|
|
(58 |
) |
|
|
(32 |
) |
|
|
(33 |
) |
| U.S. state and local |
|
|
— |
|
|
|
(6 |
) |
|
|
(2 |
) |
| Foreign |
|
|
26 |
|
|
|
23 |
|
|
|
25 |
|
| Total |
|
$ |
26 |
|
|
$ |
61 |
|
|
$ |
64 |
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| Current: |
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. federal |
|
$ |
— |
|
|
$ |
3 |
|
|
$ |
8 |
|
| U.S. state and local |
|
|
1 |
|
|
|
— |
|
|
|
1 |
|
| Foreign |
|
|
57 |
|
|
|
75 |
|
|
|
66 |
|
| Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
| U.S. federal |
|
|
(57 |
) |
|
|
(33 |
) |
|
|
(33 |
) |
| U.S. state and local |
|
|
— |
|
|
|
(6 |
) |
|
|
(2 |
) |
| Foreign |
|
|
26 |
|
|
|
23 |
|
|
|
25 |
|
| Total |
|
$ |
27 |
|
|
$ |
62 |
|
|
$ |
65 |
|
|
| Schedule of Income Taxes Paid [Table Text Block] |
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
| Income taxes paid (net of refunds) by jurisdiction: |
|
|
|
|
| U.S. federal |
|
$ |
13 |
|
| U.S. state and local |
|
|
— |
|
| Foreign: |
|
|
|
|
| China |
|
|
39 |
|
| Germany |
|
|
19 |
|
| Saudi Arabia |
|
|
8 |
|
| All other foreign jurisdictions |
|
|
19 |
|
| Total |
|
$ |
98 |
|
|
| Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] |
| |
|
Year ended December 31, 2025 |
|
| |
|
Amount |
|
|
Percent |
|
| Loss from continuing operations before income taxes |
|
$ |
(192 |
) |
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Expected income tax benefit at U.S. statutory rate of 21% |
|
$ |
(40 |
) |
|
|
21 |
% |
| Change resulting from: |
|
|
|
|
|
|
|
|
| State tax benefit, net of federal effect(1) |
|
|
— |
|
|
|
— |
|
| Foreign tax effects: |
|
|
|
|
|
|
|
|
| China: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
6 |
|
|
|
(3 |
)% |
| Withholding tax on repatriated earnings, interest and royalties |
|
|
5 |
|
|
|
(3 |
)% |
| Other |
|
|
1 |
|
|
|
(1 |
)% |
| Germany: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
6 |
|
|
|
(3 |
)% |
| Deferred tax effect of non-U.S. tax rate changes |
|
|
2 |
|
|
|
(1 |
)% |
| State trade tax benefit |
|
|
(19 |
) |
|
|
10 |
% |
| State trade tax changes in valuation allowances |
|
|
17 |
|
|
|
(9 |
)% |
| Changes in valuation allowances |
|
|
14 |
|
|
|
(7 |
)% |
| Luxembourg: |
|
|
|
|
|
|
|
|
| Nondeductible currency exchange losses |
|
|
4 |
|
|
|
(2 |
)% |
| Changes in valuation allowances |
|
|
(4 |
) |
|
|
2 |
% |
| Other |
|
|
2 |
|
|
|
(1 |
)% |
| Netherlands: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
(7 |
) |
|
|
4 |
% |
| Nontaxable currency exchange gains |
|
|
(5 |
) |
|
|
3 |
% |
| Changes in valuation allowances |
|
|
39 |
|
|
|
(20 |
)% |
| Other |
|
|
4 |
|
|
|
(2 |
)% |
| Saudi Arabia: |
|
|
|
|
|
|
|
|
| Nontaxable minority partner share of income |
|
|
(5 |
) |
|
|
3 |
% |
| Other |
|
|
(1 |
) |
|
|
1 |
% |
| Switzerland: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
(8 |
) |
|
|
4 |
% |
| Cantonal tax expense |
|
|
4 |
|
|
|
(2 |
)% |
| Turkey: |
|
|
|
|
|
|
|
|
| Changes in valuation allowances |
|
|
2 |
|
|
|
(1 |
)% |
| U.K.: |
|
|
|
|
|
|
|
|
| Changes in valuation allowances |
|
|
2 |
|
|
|
(1 |
)% |
| Other |
|
|
(1 |
) |
|
|
1 |
% |
| Other foreign jurisdictions: |
|
|
|
|
|
|
|
|
| Other |
|
|
2 |
|
|
|
(3 |
)% |
| Effect of changes in tax laws or rates enacted in the current period |
|
|
— |
|
|
|
— |
|
| Effect of cross-border tax laws |
|
|
— |
|
|
|
— |
|
| Tax credits—research and development credits |
|
|
(3 |
) |
|
|
2 |
% |
| Changes in valuation allowances |
|
|
(2 |
) |
|
|
1 |
% |
| Nontaxable or nondeductible items: |
|
|
|
|
|
|
|
|
| Other U.S. tax effects, including nondeductible expenses and other items |
|
|
1 |
|
|
|
(1 |
)% |
| Stock-based compensation |
|
|
5 |
|
|
|
(3 |
)% |
| Changes in unrecognized tax benefits |
|
|
5 |
|
|
|
(3 |
)% |
| Income tax expense and effective income tax rate |
|
$ |
26 |
|
|
|
(14 |
)% |
| |
|
Year ended December 31, 2025 |
|
| |
|
Amount |
|
|
Percent |
|
| Loss from continuing operations before income taxes |
|
$ |
(189 |
) |
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Expected income tax benefit at U.S. statutory rate of 21% |
|
$ |
(39 |
) |
|
|
21 |
% |
| Change resulting from: |
|
|
|
|
|
|
|
|
| State tax benefit, net of federal effect(1) |
|
|
— |
|
|
|
— |
|
| Foreign tax effects: |
|
|
|
|
|
|
|
|
| China: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
6 |
|
|
|
(3 |
)% |
| Withholding tax on repatriated earnings, interest and royalties |
|
|
5 |
|
|
|
(3 |
)% |
| Other |
|
|
1 |
|
|
|
(1 |
)% |
| Germany: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
6 |
|
|
|
(3 |
)% |
| Deferred tax effect of non-U.S. tax rate changes |
|
|
2 |
|
|
|
(1 |
)% |
| State trade tax benefit |
|
|
(19 |
) |
|
|
10 |
% |
| State trade tax changes in valuation allowances |
|
|
17 |
|
|
|
(9 |
)% |
| Changes in valuation allowances |
|
|
14 |
|
|
|
(7 |
)% |
| Luxembourg: |
|
|
|
|
|
|
|
|
| Nondeductible currency exchange losses |
|
|
4 |
|
|
|
(2 |
)% |
| Changes in valuation allowances |
|
|
(4 |
) |
|
|
2 |
% |
| Other |
|
|
2 |
|
|
|
(1 |
)% |
| Netherlands: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
(7 |
) |
|
|
4 |
% |
| Nontaxable currency exchange gains |
|
|
(5 |
) |
|
|
3 |
% |
| Changes in valuation allowances |
|
|
39 |
|
|
|
(21 |
)% |
| Other |
|
|
4 |
|
|
|
(2 |
)% |
| Saudi Arabia: |
|
|
|
|
|
|
|
|
| Nontaxable minority partner share of income |
|
|
(5 |
) |
|
|
3 |
% |
| Other |
|
|
(1 |
) |
|
|
1 |
% |
| Switzerland: |
|
|
|
|
|
|
|
|
| Statutory tax rate difference |
|
|
(8 |
) |
|
|
4 |
% |
| Cantonal tax expense |
|
|
4 |
|
|
|
(2 |
)% |
| Turkey: |
|
|
|
|
|
|
|
|
| Changes in valuation allowances |
|
|
2 |
|
|
|
(1 |
)% |
| U.K.: |
|
|
|
|
|
|
|
|
| Changes in valuation allowances |
|
|
2 |
|
|
|
(1 |
)% |
| Other |
|
|
(1 |
) |
|
|
1 |
% |
| Other foreign jurisdictions: |
|
|
|
|
|
|
|
|
| Other |
|
|
2 |
|
|
|
(2 |
)% |
| Effect of changes in tax laws or rates enacted in the current period |
|
|
— |
|
|
|
— |
|
| Effect of cross-border tax laws |
|
|
— |
|
|
|
— |
|
| Tax credits—research and development credits |
|
|
(3 |
) |
|
|
2 |
% |
| Changes in valuation allowances |
|
|
(2 |
) |
|
|
1 |
% |
| Nontaxable or nondeductible items: |
|
|
|
|
|
|
|
|
| Other U.S. tax effects, including nondeductible expenses and other items |
|
|
1 |
|
|
|
(1 |
)% |
| Stock-based compensation |
|
|
5 |
|
|
|
(3 |
)% |
| Changes in unrecognized tax benefits |
|
|
5 |
|
|
|
(3 |
)% |
| Income tax expense and effective income tax rate |
|
$ |
27 |
|
|
|
(14 |
)% |
| |
|
Year ended December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| (Loss) income from continuing operations before income taxes |
|
$ |
(39 |
) |
|
$ |
99 |
|
| |
|
|
|
|
|
|
|
|
| Expected tax (benefit) expense at U.S. statutory rate of 21% |
|
$ |
(8 |
) |
|
$ |
21 |
|
| Change resulting from: |
|
|
|
|
|
|
|
|
| State tax expense, net of federal benefit |
|
|
(7 |
) |
|
|
(1 |
) |
| Non-U.S. tax rate differentials |
|
|
(4 |
) |
|
|
— |
|
| Income tax settlement related to 2017 U.S. Tax Reform Act |
|
|
5 |
|
|
|
— |
|
| Loss from liquidation of subsidiaries |
|
|
10 |
|
|
|
— |
|
| Gain on acquisition of assets, net |
|
|
(13 |
) |
|
|
— |
|
| Impact of equity method investments |
|
|
(17 |
) |
|
|
(28 |
) |
| Non-U.S. withholding tax on repatriated earnings, interest and royalties, net of U.S. foreign tax credits |
|
|
14 |
|
|
|
12 |
|
| Tax authority audits and dispute resolutions |
|
|
4 |
|
|
|
5 |
|
| Non-U.S. income subject to U.S. tax not offset by U.S. foreign tax credits |
|
|
(6 |
) |
|
|
3 |
|
| Deferred tax effect of non-U.S. tax rate changes |
|
|
(2 |
) |
|
|
— |
|
| Stock-based compensation |
|
|
3 |
|
|
|
— |
|
| Other non-U.S. tax effects, including nondeductible expenses and transfer pricing adjustments |
|
|
8 |
|
|
|
5 |
|
| Other U.S. tax effects, including nondeductible expenses and other credits |
|
|
(1 |
) |
|
|
2 |
|
| Change in valuation allowance |
|
|
75 |
|
|
|
45 |
|
| Total income tax expense |
|
$ |
61 |
|
|
$ |
64 |
|
| |
|
Year ended December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| (Loss) income from continuing operations before income taxes |
|
$ |
(36 |
) |
|
$ |
102 |
|
| |
|
|
|
|
|
|
|
|
| Expected tax (benefit) expense at U.S. statutory rate of 21% |
|
$ |
(7 |
) |
|
$ |
22 |
|
| Change resulting from: |
|
|
|
|
|
|
|
|
| State tax expense, net of federal benefit |
|
|
(7 |
) |
|
|
(1 |
) |
| Non-U.S. tax rate differentials |
|
|
(4 |
) |
|
|
— |
|
| Income tax settlement related to 2017 U.S. Tax Reform Act |
|
|
5 |
|
|
|
— |
|
| Loss from liquidation of subsidiaries |
|
|
10 |
|
|
|
— |
|
| Gain on acquisition of assets, net |
|
|
(13 |
) |
|
|
— |
|
| Impact of equity method investments |
|
|
(17 |
) |
|
|
(28 |
) |
| Non-U.S. withholding tax on repatriated earnings, interest and royalties, net of U.S. foreign tax credits |
|
|
14 |
|
|
|
12 |
|
| Tax authority audits and dispute resolutions |
|
|
4 |
|
|
|
5 |
|
| Non-U.S. income subject to U.S. tax not offset by U.S. foreign tax credits |
|
|
(6 |
) |
|
|
3 |
|
| Deferred tax effect of non-U.S. tax rate changes |
|
|
(2 |
) |
|
|
— |
|
| Stock-based compensation |
|
|
3 |
|
|
|
— |
|
| Other non-U.S. tax effects, including nondeductible expenses and transfer pricing adjustments |
|
|
8 |
|
|
|
5 |
|
| Other U.S. tax effects, including nondeductible expenses and other credits |
|
|
(1 |
) |
|
|
2 |
|
| Change in valuation allowance |
|
|
75 |
|
|
|
45 |
|
| Total income tax expense |
|
$ |
62 |
|
|
$ |
65 |
|
|
| Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] |
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| U.S. |
|
$ |
(283 |
) |
|
$ |
(176 |
) |
|
$ |
(155 |
) |
| Non-U.S. |
|
|
91 |
|
|
|
137 |
|
|
|
254 |
|
| Total |
|
$ |
(192 |
) |
|
$ |
(39 |
) |
|
$ |
99 |
|
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| U.S. |
|
$ |
(280 |
) |
|
$ |
(173 |
) |
|
$ |
(152 |
) |
| Non-U.S. |
|
|
91 |
|
|
|
137 |
|
|
|
254 |
|
| Total |
|
$ |
(189 |
) |
|
$ |
(36 |
) |
|
$ |
102 |
|
|
| Schedule of Deferred Tax Assets and Liabilities [Table Text Block] |
| |
|
December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Deferred income tax assets: |
|
|
|
|
|
|
|
|
| Net operating loss carryforwards |
|
$ |
435 |
|
|
$ |
289 |
|
| Operating leases |
|
|
93 |
|
|
|
95 |
|
| Pension and other employee compensation |
|
|
45 |
|
|
|
57 |
|
| Deferred interest |
|
|
133 |
|
|
|
104 |
|
| Capitalized research and development costs |
|
|
23 |
|
|
|
56 |
|
| Property, plant and equipment |
|
|
21 |
|
|
|
25 |
|
| Intangible assets |
|
|
2 |
|
|
|
9 |
|
| Intercompany prepayments |
|
|
— |
|
|
|
4 |
|
| Other, net |
|
|
63 |
|
|
|
49 |
|
| Total |
|
$ |
815 |
|
|
$ |
688 |
|
| Deferred income tax liabilities: |
|
|
|
|
|
|
|
|
| Property, plant and equipment |
|
$ |
(292 |
) |
|
$ |
(284 |
) |
| Operating leases |
|
|
(89 |
) |
|
|
(95 |
) |
| Intangible assets |
|
|
(66 |
) |
|
|
(74 |
) |
| Pension and other employee compensation |
|
|
(75 |
) |
|
|
(52 |
) |
| Outside basis difference in subsidiaries |
|
|
(47 |
) |
|
|
(42 |
) |
| Unrealized currency gains |
|
|
(5 |
) |
|
|
(16 |
) |
| Other, net |
|
|
(8 |
) |
|
|
(5 |
) |
| Total |
|
$ |
(582 |
) |
|
$ |
(568 |
) |
| Net deferred tax asset before valuation allowance |
|
$ |
233 |
|
|
$ |
120 |
|
| Valuation allowance—net operating losses, deferred interest and other |
|
|
(340 |
) |
|
|
(255 |
) |
| Net deferred tax liability |
|
$ |
(107 |
) |
|
$ |
(135 |
) |
| Non-current deferred tax asset |
|
$ |
49 |
|
|
$ |
69 |
|
| Non-current deferred tax liability |
|
|
(156 |
) |
|
|
(204 |
) |
| Net deferred tax liability |
|
$ |
(107 |
) |
|
$ |
(135 |
) |
| |
|
December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Deferred income tax assets: |
|
|
|
|
|
|
|
|
| Net operating loss carryforwards |
|
$ |
433 |
|
|
$ |
288 |
|
| Operating leases |
|
|
93 |
|
|
|
95 |
|
| Pension and other employee compensation |
|
|
44 |
|
|
|
56 |
|
| Deferred interest |
|
|
133 |
|
|
|
104 |
|
| Capitalized research and development costs |
|
|
22 |
|
|
|
55 |
|
| Property, plant and equipment |
|
|
21 |
|
|
|
25 |
|
| Intangible assets |
|
|
2 |
|
|
|
9 |
|
| Intercompany prepayments |
|
|
— |
|
|
|
4 |
|
| Other, net |
|
|
63 |
|
|
|
49 |
|
| Total |
|
$ |
811 |
|
|
$ |
685 |
|
| Deferred income tax liabilities: |
|
|
|
|
|
|
|
|
| Property, plant and equipment |
|
$ |
(292 |
) |
|
$ |
(284 |
) |
| Operating leases |
|
|
(89 |
) |
|
|
(95 |
) |
| Intangible assets |
|
|
(66 |
) |
|
|
(74 |
) |
| Pension and other employee compensation |
|
|
(75 |
) |
|
|
(52 |
) |
| Outside basis difference in subsidiaries |
|
|
(47 |
) |
|
|
(42 |
) |
| Unrealized currency gains |
|
|
(5 |
) |
|
|
(16 |
) |
| Other, net |
|
|
(8 |
) |
|
|
(5 |
) |
| Total |
|
$ |
(582 |
) |
|
$ |
(568 |
) |
| Net deferred tax asset before valuation allowance |
|
$ |
229 |
|
|
$ |
117 |
|
| Valuation allowance—net operating losses, deferred interest and other |
|
|
(340 |
) |
|
|
(255 |
) |
| Net deferred tax liability |
|
$ |
(111 |
) |
|
$ |
(138 |
) |
| Non-current deferred tax asset |
|
|
49 |
|
|
|
69 |
|
| Non-current deferred tax liability |
|
|
(160 |
) |
|
|
(207 |
) |
| Net deferred tax liability |
|
$ |
(111 |
) |
|
$ |
(138 |
) |
|
| Summary of Valuation Allowance [Table Text Block] |
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| Valuation allowances as of January 1 |
|
$ |
255 |
|
|
$ |
221 |
|
|
$ |
169 |
|
| Valuation allowances as of December 31 |
|
|
340 |
|
|
|
255 |
|
|
|
221 |
|
| Net increase |
|
|
(85 |
) |
|
|
(34 |
) |
|
|
(52 |
) |
| Foreign currency movements |
|
|
26 |
|
|
|
(13 |
) |
|
|
3 |
|
| Decrease to deferred tax assets with no impact on operating tax expense, including an offsetting (decrease) increase to valuation allowances |
|
|
(10 |
) |
|
|
(28 |
) |
|
|
4 |
|
| Change in valuation allowances per rate reconciliation |
|
$ |
(69 |
) |
|
$ |
(75 |
) |
|
$ |
(45 |
) |
| Components of change in valuation allowances affecting tax expense: |
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-tax income and losses in jurisdictions with valuation allowances resulting in no tax expense or benefit |
|
$ |
(64 |
) |
|
$ |
(46 |
) |
|
$ |
(30 |
) |
| Releases of valuation allowances in various jurisdictions |
|
|
8 |
|
|
|
— |
|
|
|
1 |
|
| Establishments of valuation allowances in various jurisdictions |
|
|
(13 |
) |
|
|
(29 |
) |
|
|
(16 |
) |
| Change in valuation allowances per rate reconciliation |
|
$ |
(69 |
) |
|
$ |
(75 |
) |
|
$ |
(45 |
) |
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| Valuation allowances as of January 1 |
|
$ |
255 |
|
|
$ |
221 |
|
|
$ |
169 |
|
| Valuation allowances as of December 31 |
|
|
340 |
|
|
|
255 |
|
|
|
221 |
|
| Net increase |
|
|
(85 |
) |
|
|
(34 |
) |
|
|
(52 |
) |
| Foreign currency movements |
|
|
26 |
|
|
|
(13 |
) |
|
|
3 |
|
| Decrease to deferred tax assets with no impact on operating tax expense, including an offsetting (decrease) increase to valuation allowances |
|
|
(10 |
) |
|
|
(28 |
) |
|
|
4 |
|
| Change in valuation allowances per rate reconciliation |
|
$ |
(69 |
) |
|
$ |
(75 |
) |
|
$ |
(45 |
) |
| Components of change in valuation allowances affecting tax expense: |
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-tax income and losses in jurisdictions with valuation allowances resulting in no tax expense or benefit |
|
$ |
(64 |
) |
|
$ |
(46 |
) |
|
$ |
(30 |
) |
| Releases of valuation allowances in various jurisdictions |
|
|
8 |
|
|
|
— |
|
|
|
1 |
|
| Establishments of valuation allowances in various jurisdictions |
|
|
(13 |
) |
|
|
(29 |
) |
|
|
(16 |
) |
| Change in valuation allowances per rate reconciliation |
|
$ |
(69 |
) |
|
$ |
(75 |
) |
|
$ |
(45 |
) |
|
| Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] |
| |
|
2025 |
|
|
2024 |
|
| Unrecognized tax benefits as of January 1 |
|
$ |
5 |
|
|
$ |
5 |
|
| Gross increases and decreases—tax positions taken during a prior period |
|
|
1 |
|
|
|
— |
|
| Gross increases and decreases—tax positions taken during the current period |
|
|
2 |
|
|
|
1 |
|
| Reductions resulting from the lapse of statues of limitations |
|
|
— |
|
|
|
(1 |
) |
| Foreign currency movements |
|
|
1 |
|
|
|
— |
|
| Unrecognized tax benefits as of December 31 |
|
$ |
9 |
|
|
$ |
5 |
|
|
| Schedule of Unrecognized Tax Benefits, Income Tax Penalties and Interest Recognized in Financial Statement [Table Text Block] |
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| Interest included in tax expense |
|
$ |
2 |
|
|
$ |
2 |
|
|
$ |
3 |
|
| |
|
December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Accrued liability for interest |
|
$ |
10 |
|
|
$ |
8 |
|
|
| Summary of Open Tax Years [Table Text Block] |
| Tax jurisdiction |
|
Open tax years |
| Belgium |
|
2024 and later |
| China |
|
2015 and later |
| Germany |
|
2018 and later |
| Hong Kong |
|
2019 and later |
| India |
|
2022 and later |
| Mexico |
|
2022 and later |
| Switzerland |
|
2017 and later |
| The Netherlands |
|
2021 and later |
| United Kingdom |
|
2023 and later |
| United States federal |
|
2017 and later |
|